Skip to main content

and
  1. Article

    Open Access

    Does Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) Predict the Obstetric Outcome in Antiphospholipid Antibody Carriers? A Single-Center Study

    The adjusted Global Antiphospholipid Syndrome (APS) Score (aGAPSS) is a tool proposed to quantify the risk for antiphospholipid antibody (aPL)-related clinical manifestations. However, aGAPSS has been validate...

    Sara Del Barrio-Longarela in Clinical Reviews in Allergy & Immunology (2022)

  2. Article

    Open Access

    Ambrisentan use in a HIV-1 infected patient with end-stage renal disease and pulmonary hypertension: minimal removal by hemodialysis - a case report

    Ambrisentan is a selective endothelin receptor antagonist used for the treatment of pulmonary arterial hypertension (PAH). Little is known about ambrisentan removal by hemodialysis in patients with end-stage r...

    José Ramón Santos, Ana Merino, Walter E. Haefeli, Cristina Miranda in BMC Nephrology (2020)